CLSI EP18-A2 识别和控制实验室误差源的风险管理技术.pdf

CLSI EP18-A2 识别和控制实验室误差源的风险管理技术.pdf

  1. 1、本文档共100页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
EP18-A2 Vol. 29 No. 26 Replaces EP18-A Vol. 22 No. 28 Risk Management Techniques to Identify and Control Laboratory Error Sources; Approved Guideline—Second Edition This guideline describes risk management techniques that will aid in identifying, understanding, and managing sources of failure (potential failure modes) and help to ensure correct results. Although intended primarily for in vitro diagnostics, this document will also serve as a reference for clinical laboratory managers and supervisors who wish to learn about risk management techniques and processes. A guideline for global application developed through the Clinical and Laboratory Standards Institute consensus process. Licensed to: Jill Runyen Abbott This document is protected by copyright. CLSI order # Subscription, id # 468452, Downloaded on 12/2/2009. Clinical and Laboratory Standards Institute Advancing Quality in Health Care Testing Clinical and Laboratory Standards Institute (CLSI, Most documents are subject to two levels of consensus— formerly NCCLS) is an international, interdisciplinary, “proposed” and “approved.” Depending on the need for nonprofit, standards-developing, and educational field evaluation or data collection, documents may also be organization that promot

文档评论(0)

千年硕鼠 + 关注
实名认证
内容提供者

药学医师证持证人

10年深耕医疗器械、体外诊断试剂领域

认证主体李**
领域认证该用户于2023年05月20日上传了药学医师证

1亿VIP精品文档免费下

相关文档

相关课程推荐